Cargando…
Never too old to fight breast cancer: A case report
RATIONALE: Breast cancer is the most common cancer affecting females worldwide and its lifetime risk increases with age. Human epidermal growth factor receptor gene-2 (HER-2) positive breast cancer represents about 20% of all breast cancers, 1 out of 10 is diagnosed in women over 70 years of age. It...
Autores principales: | Zuradelli, Monica, Masci, Giovanna, Ferraro, Emanuela, Losurdo, Agnese, De Sanctis, Rita, Torrisi, Rosalba, Santoro, Armando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851756/ https://www.ncbi.nlm.nih.gov/pubmed/29489698 http://dx.doi.org/10.1097/MD.0000000000009981 |
Ejemplares similares
-
Clinical predictors of cardiac toxicity in HER2-positive early breast cancer patients treated with adjuvant s.c. versus i.v. trastuzumab
por: De Sanctis, Rita, et al.
Publicado: (2021) -
Sticking to the Rules: Outcome and Success Rate of Guideline-Based Diarrhea Management in Metastatic Breast Cancer Patients Treated with Abemaciclib
por: Jacobs, Flavia, et al.
Publicado: (2023) -
Low-dose “metronomic chemotherapy” with oral cyclophosphamide and methotrexate in metastatic breast cancer: a case report of extraordinarily prolonged clinical benefit
por: Masci, G, et al.
Publicado: (2012) -
Insights for the application of TILs and AR in the treatment of TNBC in routine clinical practice
por: Losurdo, Agnese, et al.
Publicado: (2020) -
Never Too Old to Get Rich
por: Hannon, Kerry
Publicado: (2019)